DICE Therapeutics (DICE) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free DICE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQ3 2024 Resmed Inc Earnings Callfinance.yahoo.com - April 26 at 7:15 AMMinishoot' Adventures Hits Steam: A Bullet-Hell Bonanza with a Zelda Twistmsn.com - April 3 at 3:29 AMVoyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easierseekingalpha.com - March 8 at 4:00 PMStoke City player ratings vs Cardiff as Potters sink into relegation zonemsn.com - February 24 at 5:46 PMAbercrombie Announces Official Partnership With McLaren Racing, Features Race Car in Fifth Avenue Storees-us.finanzas.yahoo.com - January 31 at 1:15 PM15 Best Acne Treatment Products For Teens in 2024msn.com - January 30 at 10:10 PMStar Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officerfinance.yahoo.com - January 3 at 9:35 AMAltamira Therapeutics stock rises after it regains compliance with Nasdaqmsn.com - December 30 at 7:55 AMCan a Big Pharma Ever Be Worth $1 Trillion?msn.com - November 29 at 12:11 PMQ3 2023 Eli Lilly and Co Earnings Calluk.finance.yahoo.com - November 4 at 12:06 AMEli Lilly to buy Dice Therapeutics for $2.4 billioninvesting.com - October 25 at 6:40 AMImmetas Therapeutics and GC Biopharma Announce Research Collaboration to Discover and Develop mRNA Therapeutics to Treat Autoimmune Diseaseses-us.finanzas.yahoo.com - October 12 at 1:42 AMPoint Biopharma shares storm ahead 84% after Eli Lily's $1.4bn bidproactiveinvestors.com - October 3 at 12:25 PMIs Eli Lilly Stock A Buy Now That It Has Topped A Profit-Taking Zone?msn.com - September 29 at 5:30 PMWells Fargo Sticks to Their Hold Rating for Incyte (INCY)markets.businessinsider.com - September 11 at 6:52 AMWhy These 3 Large Caps Are Bucking the August Slump (DICE)marketbeat.com - August 22 at 7:49 AMY Intercept Hong Kong Ltd Takes Position in DICE Therapeutics, Inc. (NASDAQ:DICE)marketbeat.com - August 21 at 4:52 AMWhat 9 Analyst Ratings Have To Say About DICE Therapeuticsmarkets.businessinsider.com - August 9 at 8:58 PMEli Lilly and Company: Lilly Completes Acquisition of DICE Therapeuticsfinanznachrichten.de - August 9 at 2:37 PMHC Wainwright & Co. Reiterates DICE Therapeutics (DICE) Neutral Recommendationmsn.com - August 9 at 2:37 PMLilly Completes Acquisition of DICE Therapeuticsfinance.yahoo.com - August 9 at 9:37 AMVersor Investments LP Invests $286,000 in DICE Therapeutics, Inc. (NASDAQ:DICE)marketbeat.com - August 9 at 8:11 AMmarketbeat.com - August 9 at 6:09 AMEli Lilly and Company: Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline Advancementsfinanznachrichten.de - August 8 at 8:42 AMLilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline Advancementsmarkets.businessinsider.com - August 8 at 8:42 AMDICE Therapeutics, Inc. (NASDAQ:DICE) Shares Sold by SG Americas Securities LLCmarketbeat.com - August 8 at 4:23 AMJump Financial LLC Has $496,000 Stock Holdings in DICE Therapeutics, Inc. (NASDAQ:DICE)marketbeat.com - August 7 at 7:35 AMLilly Extends Tender Offer To Acquire DICEmarkets.businessinsider.com - July 25 at 8:42 AMLilly Announces Extension of Tender Offer to Acquire DICEfinance.yahoo.com - July 25 at 8:42 AMDrugmakers’ deal making will plow ahead despite antitrust scrutiny, analysts saymsn.com - July 12 at 5:57 PMDICE Therapeutics (DICE) Price Target Decreased by 19.70% to 50.21msn.com - July 6 at 9:17 PMMergers Are Down, but These 2 Sectors Are Boomingfinance.yahoo.com - June 27 at 8:49 AMShort Volatility Alert: Dice Therapeuticsbenzinga.com - June 26 at 5:08 PMNeedham Downgrades DICE Therapeutics (DICE)msn.com - June 26 at 12:07 PMNeedham Downgrades DICE Therapeutics to Holdbenzinga.com - June 26 at 7:07 AMNorthpond Ventures Gp, Llc Sells 2,492,871 Shares of DICE Therapeutics, Inc. (NASDAQ:DICE) Stockmarketbeat.com - June 23 at 8:11 PMBrokers Issue Forecasts for DICE Therapeutics, Inc.'s FY2027 Earnings (NASDAQ:DICE)marketbeat.com - June 23 at 8:30 AMDice Therapeutics (DICE) Receives a New Rating from a Top Analystmarkets.businessinsider.com - June 21 at 4:39 PMRed Hot Eli Lilly Rolls the DICE With Its Latest Biotech Takeover (DICE)marketbeat.com - June 21 at 9:34 AMCantor Fitzgerald Downgrades DICE Therapeutics (DICE)msn.com - June 21 at 6:38 AMCanaccord Genuity Downgrades DICE Therapeutics (DICE)msn.com - June 21 at 6:38 AMAnalyst Expectations for DICE Therapeutics's Futuremsn.com - June 20 at 9:18 PMThe Lilly-Dice Biotech Buyout Deals Short Sellers Another Blowwsj.com - June 20 at 4:17 PMEli Lilly's $2.4 Billion Acquisition of Dice Therapeutics: What Investors Need to Knowfool.com - June 20 at 4:17 PMWhy DICE Therapeutics Stock Is Soaring Tuesdaymarkets.businessinsider.com - June 20 at 11:17 AMLilly Decides to Roll the Dice: My Plan for the Stock Nowfinance.yahoo.com - June 20 at 11:17 AMPayPal-KKR deal, Alibaba shares fall, Eli Lilly-Dice Therapeutics deal: Trending tickersfinance.yahoo.com - June 20 at 11:17 AMDice Therapeutics Stock Catapults To Record High On $2.4 Billion Eli Lilly Buyoutfinance.yahoo.com - June 20 at 11:17 AM1,038,125 Shares in DICE Therapeutics, Inc. (NASDAQ:DICE) Acquired by Alkeon Capital Management LLCmarketbeat.com - June 14 at 8:54 AMDICE Therapeutics to Host R&D Investor Event on Tuesday, June 20, 2023finance.yahoo.com - June 13 at 6:46 PM Get DICE Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DICE and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide DICE Media Mentions By Week DICE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DICE News Sentiment▼0.000.33▲Average Medical News Sentiment DICE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DICE Articles This Week▼11▲DICE Articles Average Week Get DICE Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DICE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Crinetics Pharmaceuticals News Bausch Health Companies News Verona Pharma News Akero Therapeutics News Centessa Pharmaceuticals News Scholar Rock News RayzeBio News Icosavax News Gracell Biotechnologies News ALX Oncology News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DICE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceDonald Trump Just Predicted "America's Greatest Defeat"Birch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DICE Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
